Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Apr;486(4):865-869.
doi: 10.1007/s00428-025-04071-z. Epub 2025 Mar 22.

DEK::AFF2 rearranged neoplasm with undifferentiated morphology and neuroendocrine phenotype in a pediatric patient

Affiliations
Case Reports

DEK::AFF2 rearranged neoplasm with undifferentiated morphology and neuroendocrine phenotype in a pediatric patient

Emma Rullo et al. Virchows Arch. 2025 Apr.

Abstract

The advent of next-generation sequencing (NGS) has greatly enhanced the identification of morphologically and/or phenotypically unusual neoplasms. We report an undifferentiated carcinoma with a DEK::AFF2 fusion in a 13-year-old female from the head and neck region. DEK::AFF2 rearranged non-keratinizing squamous cell carcinoma (NKSCC) has been recognized as a distinct entity in the WHO classification of head and neck tumors, typically affecting adults. The case presented is unusual for both the patient's age and the undifferentiated morphology, which includes neuroendocrine immunophenotypic features, such as focal synaptophysin staining, dot-like cytokeratin expression, and only scattered cells positive for p63 and p40. Additional cases are needed to determine whether these features define a distinct subset of DEK::AFF2 rearranged neoplasms and to assess their potential correlation with a younger age of occurrence.

Keywords: DEK:AFF2 rearranged; Head and neck carcinoma; Neuroendocrine; Pediatric; Squamous carcinoma; Undifferentiated neoplasm.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: Ethical approval is not required as this is a case report. All the clinical and pathologic investigations detailed in the manuscript have been conducted in accordance with the Declaration of Helsinki and its later amendments. Competing interests: The authors declare no competing interests. Patient consent statement: Informed consent for publication of data and images was obtained from the parents as the subject of the report is a minor. Permission to reproduce materials from other sources: No materials from other sources is reproduced within the submitted article. Clinical trial registration: Not applicable.

Similar articles

Cited by

References

    1. Rooper LM, Agaimy A, Dickson BC, Dueber JC, Eberhart CG, Gagan J, Hartmann A, Khararjian A, London NR, MacMillan CM, Palsgrove DN, Nix JS, Sandison A, Stoehr R, Truong T, Weinreb I, Bishop JA (2021) DEK-AFF2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol 45(12):1682–1693. https://doi.org/10.1097/PAS.0000000000001741 - DOI - PubMed
    1. Trinquet A, Laé M, Lépine C, Lanic MD, Lacheretz-Szablewski V, Shaar Chneker C, Goujon JM, Favier V, Costes-Martineau V (2024) Sinonasal squamous cell carcinoma with DEK::AFF2 rearrangement: an aggressive cancer with bland morphology. Am J Surg Pathol. https://doi.org/10.1097/PAS.0000000000002281
    1. Amin SE, Lewis JS Jr, Bridge JA, Hang JF, Naik U, Bishop JA, Saluja K (2024) DEK::AFF2 fusion-associated squamous cell carcinoma: a case series with literature review on an emerging and challenging entity. Head Neck Pathol 18(1):86. https://doi.org/10.1007/s12105-024-01690-x.PMID:39312022;PMCID:PMC11420419 - DOI - PubMed
    1. Agarwal A, Bhatt AA, Bathla G, Kanekar S, Soni N, Murray J, Vijay K, Vibhute P, Rhyner PH (2023) Update from the 5th edition of the WHO classification of nasal, paranasal, and skull base tumors: imaging overview with histopathologic and genetic correlation. AJNR Am J Neuroradiol. 44(10):1116–1125. https://doi.org/10.3174/ajnr.A7960 - DOI - PubMed - PMC
    1. Salgado CM, Alaggio R, Ciolfi A, Zin A, DiomediCamassei F, Pedace L et al (2023) Pediatric BCOR-altered tumors from soft tissue/kidney display specific DNA methylation profiles. Mod Pathol 36(2):100039 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources